|

Enoxaparin Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Lovenox

Pipeline

Phase 2: 1Phase 4: 2

Top Sponsors

  • Tzu-Fei Wang1
  • Kiranya Arnold1
  • European Foundation for Study of Chronic Liver Failure1

Indications

  • Cancer2
  • Acute on Chronic Liver Failure (ACLF)1
  • Decompensated Cirrhosis of Liver1
  • Liver Disease1
  • Thrombocytopenia1

Other2 trials

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Phase 2
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Phase 4

Syracuse, New York1 trial

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

SUNY Upstate

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.